Advertisement

Topics

Morphotek Inc. Company Profile

04:50 EDT 19th September 2018 | BioPortfolio

Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology. The company employs its technology to discover and develop optimized antibodies for the treatment of cancer, inflammatory, and infectious diseases. Morphotek currently has two products in clinical development and is positioned to file INDs for additional antibody products within its pipeline over the next 24 monthSince our founding in 2000, Morphotek has established itself as a leader in developing optimized monoclonal antibodies and therapeutic proteins. The company has assembled a strong pipeline of lead products in the area of cancer, inflammation and infectious disease. Our partners include world-renown research laboratories and leading biopharmaceutical companies who rely on our technologies to optimize their therapeutic and diagnostic products. These accomplishments have been facilitated through funding by top-tier venture capital groups who have contributed $38M to date to support Morphotek's operations.

Location

210 Welsh Pool Road
Exton
Pennsylvania
19341
United States of America

Contact

Phone: (610) 423-6100


News Articles [7 Associated News Articles listed on BioPortfolio]

Morphotek Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

Morphotek Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Morphotek Inc Mergers Acquisitions MA, Partnerships Alliances and Investments report include...

Bliss Biopharma of Hangzhou Licenses Cancer ADC from Morphotek

Morphotek, a US subsidiary of Japan's Eisai, granted Bliss Biopharmaceutical (Hangzhou) exclusive rights to use its eribulin-linker payload to develop a therapeutic antibody drug conjugate against an ...

Shuwen Develops Companion Diagnostics for BlissBio in New Collaboration

Shuwen Biotech of Deqing will partner with Bliss Biopharma, a one-year-old Hangzhou company, to develop companion diagnostics for BlissBio’s oncology drug candidates. Shuwen will also provide te...

Morphotek Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13032018] Prices from USD $250

SummaryMorphotek Inc Morphotek, a subsidiary of Eisai Co Ltd is a clinicalstage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal an...

Morphotek Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23042018] Prices from USD $250

SummaryMorphotek Inc Morphotek, a subsidiary of Eisai Co Ltd is a clinicalstage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal an...

Exclusive Licensing Agreement for In-house Developed Monoclonal Antibody Farletuzumab in Latin America Concluded with Eurofarma Laboratorios S.A.

TOKYO, Oct 4, 2016 - (JCN Newswire) - Eisai Co., Ltd. announced today that its research subsidiary Morphotek, Inc. has signed an exclusive licensing agreement with Eurofarma Laboratorios S.A. to deve...

Week in Review: Ping An Good Doctor Plans $1 Billion Hong Kong IPO in Mid-May

Deals and Financings Ping An Good Doctor, a China mobile healthcare app, plans a $1 billion Hong Kong IPO scheduled for mid-May that values the company at $5 billion; Panacea Venture Healthcare Fund,...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Morphotek Inc.

Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology. The company employs its technology to discover and dev...

Morphotek, Inc.

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of novel and pro...

Morphotek(R), Inc.

Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Res...

More Information about "Morphotek Inc." on BioPortfolio

We have published hundreds of Morphotek Inc. news stories on BioPortfolio along with dozens of Morphotek Inc. Clinical Trials and PubMed Articles about Morphotek Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Morphotek Inc. Companies in our database. You can also find out about relevant Morphotek Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record